STACEY HUNT: Open Payments
NPI 1558929471 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 15 payments from 10 companies in 2025. Trend: 2023 $468 · 2024 $873 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Novo Nordisk Inc | 3 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: MOUNJARO, Wegovy, UBRELVY, VRAYLAR, QULIPTA, JARDIANCE, Cologuard Collection Kit, Ozempic.
Industry payments across MO — which companies pay providers there.
